Characterization of a 90-100 kDa tumor-associated antigen in the sera of melanoma patients

David M Euhus, R. K. Gupta, D. L. Morton

Research output: Contribution to journalArticle


Using allogeneic antibody, we previously described a high-molecular-weight glycoprotein in the urine of 68% of melanoma patients. This glycoprotein has been termed urinary-tumor-associated antigen (U-TAA). A murine monoclonal antibody (MAb) specific for U-TAA (AD1-40F4) has been developed. By the use of AD1-40F4, U-TAA was detected in serum samples from 63% (33/52) of stage II and stage III melanoma patients, but from only 5% (1/20) of normal controls. This report describes the physical and immunochemical properties of U-TAA in the serum. The antigen elutes from a DEAE-Sephacel column in association with IgG in the void volume and as free antigen in a second peak. The molecular mass of the free antigen is 590-620 kDa and it sediments in the region of 28-29% sucrose by density gradient ultracentrifugation. Free antigen has an isoelectric point of 6.1. This high molecular weight antigen is composed of smaller subunits linked by reducible bonds. The AD1-40F4 reactive epitope resides on a 90-100 kDa subunit. These results provide evidence that U-TAA which is produced by melanoma cells in vitro is present in the circulation of melanoma patients.

Original languageEnglish (US)
Pages (from-to)1065-1070
Number of pages6
JournalInternational Journal of Cancer
Issue number6
Publication statusPublished - 1990
Externally publishedYes


ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this